z-logo
open-access-imgOpen Access
Ongoing Mutations in Polytreated Metastatic Cancer Patients May Create a New Chance of Treatment with Unexpected Drugs
Author(s) -
Mahmoud Mahmoud Abbass Ellithy,
Amr S. Saad,
Mahmoud Salah Abdelsalam,
Amr Elsebaei
Publication year - 2018
Publication title -
journal of cancer therapy
Language(s) - English
Resource type - Journals
eISSN - 2151-1942
pISSN - 2151-1934
DOI - 10.4236/jct.2018.911069
Subject(s) - medicine , irinotecan , pemetrexed , temozolomide , gemcitabine , dacarbazine , oncology , kras , cancer , colorectal cancer , breast cancer , erlotinib , chemotherapy , cisplatin , epidermal growth factor receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom